Table 2.

Distribution of Mutations in VH Genes of HCV-Associated Lymphomas

Patient VH Family Tumor Seq/ Clones Seq (Source) VH Gene % HomologyR:S Mutations P*D GeneJH Gene
SS  VHI  4/4 (PB) 51p1  99.0  CDR  2:0  .27  DN4  JH4b 
     FWR  2:1  .1  
SEG  VH4/5 (BM) 2/3 (PB) 51p1  96.3  CDR FWR  3:3 3:3 .25 .004  DK1  JH4b  
LC2  VHI  6/8 (PB)  51p1  95.6  CDR  4:3  .14  DXP1 JH4b  
     FWR  8:7  .0008 
LC3  VHI  4/4 (PB)  51p1  97.7  CDR 2:3  .11  DN4  JH3b  
     FWR  6:5  .004  
HAZ  VHI  3/3 (PB)  51p1  99.1  CDR  1:1  .4  D21-9 JH5b  
     FWR  1:0  .19 
LC4  VHIV  4/6 (BM) 4/4 (PB) VH4.21  95.6  CDR FWR  4:2 3:4 .19 .0002  DA1/D22-12  JH2  
SEL  VHIII 9/10 (LN)  DP51  95.2  CDR  6:2  .13  DN1 JH6b  
     FWR  3:8  .00005 
MS  VHIII  5/6 (BM) 4/4 (PB)  DP47  93.1 CDR FWR  9:1 4:7  .026 .00005  D4  JH5a 
Patient VH Family Tumor Seq/ Clones Seq (Source) VH Gene % HomologyR:S Mutations P*D GeneJH Gene
SS  VHI  4/4 (PB) 51p1  99.0  CDR  2:0  .27  DN4  JH4b 
     FWR  2:1  .1  
SEG  VH4/5 (BM) 2/3 (PB) 51p1  96.3  CDR FWR  3:3 3:3 .25 .004  DK1  JH4b  
LC2  VHI  6/8 (PB)  51p1  95.6  CDR  4:3  .14  DXP1 JH4b  
     FWR  8:7  .0008 
LC3  VHI  4/4 (PB)  51p1  97.7  CDR 2:3  .11  DN4  JH3b  
     FWR  6:5  .004  
HAZ  VHI  3/3 (PB)  51p1  99.1  CDR  1:1  .4  D21-9 JH5b  
     FWR  1:0  .19 
LC4  VHIV  4/6 (BM) 4/4 (PB) VH4.21  95.6  CDR FWR  4:2 3:4 .19 .0002  DA1/D22-12  JH2  
SEL  VHIII 9/10 (LN)  DP51  95.2  CDR  6:2  .13  DN1 JH6b  
     FWR  3:8  .00005 
MS  VHIII  5/6 (BM) 4/4 (PB)  DP47  93.1 CDR FWR  9:1 4:7  .026 .00005  D4  JH5a 

*P is the probability for obtaining the observed number of R mutations by chance. The P values were determined with the binomial probability model by analyzing all mutations from each set of clonally related transcripts together (counting each mutation only once). However, the P values were not significantly different when each clone was analyzed separately (data not shown).

or Create an Account

Close Modal
Close Modal